Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes.

Djoumerska-Alexieva, Iglika; Roumenina, Lubka; Pashov, Anastas; Dimitrov, Jordan; Hadzhieva, Maya; Lindig, Sandro; Voynova, Elisaveta; Dimitrova, Petya; Ivanovska, Nina; Bockmeyer, Clemens; Stefanova, Zvetanka; Fitting, Catherine; Bläss, Markus; Claus, Ralf; von Gunten, Stephan; Kaveri, Srini; Cavaillon, Jean-Marc; Bauer, Michael; Vassilev, Tchavdar (2015). Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response Syndromes. Molecular medicine, 21(1), p. 1. Feinstein Institute for Medical Research 10.2119/molmed.2014.00224

[img]
Preview
Text
von Gunten_Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (2MB) | Preview
[img] Text
14_224_Djoumerska-Alexieva.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (857kB) | Request a copy

Sepsis is a major cause for death worldwide. Numerous interventional trials with agents neutralizing single pro-inflammatory mediators have failed to improve survival in sepsis and aseptic systemic inflammatory response syndromes. This failure could well be explained by the widespread gene expression dysregulation known as "genomic storm" in these patients. A multifunctional polyspecific therapeutic agent might be needed to thwart the effects of this "storm". Licensed pooled intravenous immunoglobulin preparations seemed to be a promising candidate but they have also failed in their present form to prevent sepsis-related death. We report here the protective effect of a single dose of intravenous immunoglobulin preparations with additionally enhanced polyspecificity in three models of sepsis and aseptic systemic inflammation. The modification of the pooled immunoglobulin G molecules by exposure to ferrous ions resulted in their newly acquired ability to bind some pro-inflammatory molecules, complement components and endogenous "danger" signals. The improved survival in endotoxemia was associated with serum levels of pro-inflammatory cytokines, diminished complement consumption and normalization of the coagulation time. We suggest that intravenous immunoglobulin preparations with additionally enhanced polyspecificity have a clinical potential in sepsis and related systemic inflammatory syndromes.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology

UniBE Contributor:

von Gunten, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1076-1551

Publisher:

Feinstein Institute for Medical Research

Language:

English

Submitter:

Debora Scherrer

Date Deposited:

08 Apr 2016 15:20

Last Modified:

09 Sep 2017 05:59

Publisher DOI:

10.2119/molmed.2014.00224

PubMed ID:

26701312

BORIS DOI:

10.7892/boris.79535

URI:

https://boris.unibe.ch/id/eprint/79535

Actions (login required)

Edit item Edit item
Provide Feedback